| Amplification of EMSY, a novel oncogene on 11q13, in high grade ovarian surface epithelial carcinomas. | ovarian, |
| Findings support the role of EMSY as a key oncogene within the 11q13 amplicon in ovarian cancer. | ovarian, |
| EMSY amplification does occur independently of CCND1 amplification in a minority of familial breast cancers, supporting its role as a possible breast cancer oncogene | breast, |
| The breast cancer oncogene EMSY represses transcription of antimetastatic microRNA miR-31. | breast, |
| Our study demonstrated that EMSY played an oncogenic role in the progression of ovarian cancer cells and EMSY might be a promising target for the treatment | ovarian, |